NVIDIA (NVDA) Earnings Analysis
NVIDIA (NVDA) next reports earnings on 2026-08-26, consensus EPS 2.09 USD. Last quarter (2026-05-20) it beat with EPS 1.87 USD vs 1.76 USD est (+6.3%). It has beaten estimates in 8/8 recent quarters (100%). Trailing P/E 32.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NVDA next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | 2.09 USD |
| Revenue estimate | 91.81B |
NVDA earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-20 | 1.87 USD | 1.76 USD | +6.3% | Beat |
| 2026-02-25 | 1.62 USD | 1.54 USD | +5.2% | Beat |
| 2025-11-19 | 1.3 USD | 1.26 USD | +3.2% | Beat |
| 2025-08-27 | 1.05 USD | 1.01 USD | +4% | Beat |
| 2025-05-28 | 0.81 USD | 0.737 USD | +9.9% | Beat |
| 2025-02-26 | 0.89 USD | 0.848 USD | +5% | Beat |
| 2024-11-20 | 0.81 USD | 0.75 USD | +8% | Beat |
| 2024-08-28 | 0.68 USD | 0.645 USD | +5.4% | Beat |
Beat rate: 8/8 (100%) over reported quarters with consensus data.
NVDA valuation and analyst view
| Trailing P/E | 32.33 |
|---|---|
| Trailing EPS | 6.572 USD |
| Price / book | 26.35 |
| Dividend yield | 0.13% |
| Market cap | 5186.44B |
| Analyst consensus | Buy (60 buy / 16 hold / 3 sell) |
| Avg price target | 317.96 USD |
Related research pages
Frequently asked questions
When is NVIDIA (NVDA)'s next earnings date?
NVIDIA is next scheduled to report on 2026-08-26, with a consensus EPS estimate of 2.09 USD and revenue estimate of 91.81B.
Did NVDA beat earnings last quarter?
In its 2026-05-20 report, NVDA posted EPS of 1.87 USD versus a 1.76 USD estimate — a beat of 6.3%.
What is NVDA's earnings track record?
Over the last 8 reported quarters with consensus data, NVDA beat estimates 8 times (100%).
What is NVDA's current P/E ratio and EPS?
NVDA trades at a trailing P/E of 32.33 on trailing EPS of 6.57222267973318 USD.
What do analysts rate NVDA?
Analyst consensus is "Buy" across 79 ratings (2 strong buy, 58 buy, 16 hold, 3 sell, 0 strong sell). Average 12-month price target: 317.96 USD.